Alnylam Pharmaceuticals (ALNY)
104.39
-3.08 -2.87%
NASDAQ
Jul 16, 12:32
Delayed 2m
USD
View All Key Stats
ALNY Key Stats
| Income Statement | |
| Revenue (TTM) | 92.85M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -5.58 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -524.80M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -644.8% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 10.49B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 105.71 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 5.980 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | -176.92M |
| Return on Equity (TTM) | Upgrade |
View All ALNY News
ALNY News
-
WireHeadlineTime (ET)
-
Yahoo07/14 08:07
-
Yahoo07/09 09:37
-
Yahoo07/07 08:07
-
SA Breaking News07/06 11:47
-
Yahoo07/06 10:59
-
Yahoo07/05 16:27
-
MT Newswires07/05 05:32
-
Business Wire07/04 17:10
-
Yahoo06/28 17:31
-
Globe Newswire06/27 08:15
View All Events
ALNY Events
| Date | Type | Description |
|---|---|---|
| 08/09/2018 | Misc | Alnylam Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2018 |
| 08/09/2018 | Earnings | Alnylam Pharmaceuticals Inc Second Quarter Earnings Results in 2018 |
| 05/10/2018 | Misc | Alnylam Pharmaceuticals Inc Annual General Meeting in 2017 |
| 05/03/2018 16:30 EDT | Misc | Alnylam Pharmaceuticals Inc First Quarter Earnings Conference Call in 2018 |
| 05/03/2018 | Earnings | Alnylam Pharmaceuticals Inc First Quarter Earnings Results in 2018 |
| 02/15/2018 | Misc | Alnylam Pharmaceuticals Inc Annual Report in 2017 |
| 02/08/2018 | Earnings | Alnylam Pharmaceuticals Inc Fourth Quarter Earnings Results in 2017 |
| 02/08/2018 08:30 EST | Misc | Alnylam Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2017 |
| 11/07/2017 16:30 EDT | Misc | Alnylam Pharmaceuticals Inc Third Quarter Earnings Conference Call in 2017 |
| 11/07/2017 | Earnings | Alnylam Pharmaceuticals Inc Third Quarter Earnings in 2017 Release |
ALNY Fundamentals
Income Statement View Statement
ALNY Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
ALNY One Page Reports
- One Page Report Download
ALNY Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 104.39 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.alnylam.com
- Investor Relations URL: http://investors.alnylam.com/index.cfm
- HQ State/Province: Massachusetts
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Mid Cap/Growth
- Next Earnings Release: Aug. 09, 2018
- Last Earnings Release: May. 03, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Alnylam Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in developing novel therapeutics based on RNA interference, or RNAi. RNAi is a naturally occurring biological pathway within cells for regulating the expression of specific genes.
ALNY Excel Add-In Codes
- Name: =YCI("ALNY","name")
- Description: =YCI("ALNY","description")
- Sector: =YCI("ALNY","sector")
- Industry: =YCI("ALNY","industry")
- Est. Current Fiscal Year End: =YCI("ALNY","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other ALNY Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ALNY Tweets Stocktwits
Advertisement
